(2-Methoxyethoxy)methyl 5-((3-(4-cyclopropyl-1,2,3,4-tetrahydroquinoxaline-1-carbonyl)pyridin-4-yl)oxy)benzofuran-3-carboxylate

ID: ALA4793377

Chembl Id: CHEMBL4793377

PubChem CID: 156705085

Max Phase: Preclinical

Molecular Formula: C30H29N3O7

Molecular Weight: 543.58

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COCCOCOC(=O)c1coc2ccc(Oc3ccncc3C(=O)N3CCN(C4CC4)c4ccccc43)cc12

Standard InChI:  InChI=1S/C30H29N3O7/c1-36-14-15-37-19-39-30(35)24-18-38-27-9-8-21(16-22(24)27)40-28-10-11-31-17-23(28)29(34)33-13-12-32(20-6-7-20)25-4-2-3-5-26(25)33/h2-5,8-11,16-18,20H,6-7,12-15,19H2,1H3

Standard InChI Key:  SGVIYGVVOOCNSC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4793377

    ---

Associated Targets(Human)

GPBAR1 Tchem G-protein coupled bile acid receptor 1 (1723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpbar1 G-protein coupled bile acid receptor 1 (577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 543.58Molecular Weight (Monoisotopic): 543.2006AlogP: 5.03#Rotatable Bonds: 10
Polar Surface Area: 103.57Molecular Species: NEUTRALHBA: 9HBD:
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.59CX LogP: 3.79CX LogD: 3.79
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.15Np Likeness Score: -0.68

References

1. Han F,Ning M,Cao H,Ye Y,Feng Y,Leng Y,Shen J.  (2020)  Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects.,  203  [PMID:32682201] [10.1016/j.ejmech.2020.112619]

Source